BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22811998)

  • 1. [Combinatorial RNAi and its application in cancer gene therapy].
    Fei LN; Wang QZ; Xu RA
    Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial RNAi: a winning strategy for the race against evolving targets?
    Grimm D; Kay MA
    Mol Ther; 2007 May; 15(5):878-88. PubMed ID: 17311009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference--a silent but an efficient therapeutic tool.
    Ramachandran PV; Ignacimuthu S
    Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference in cancer.
    Gartel AL; Kandel ES
    Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of RNA interference in cancer therapy.
    Phalon C; Rao DD; Nemunaitis J
    Expert Rev Mol Med; 2010 Aug; 12():e26. PubMed ID: 20716384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy.
    Yan R; Hallam A; Stockley PG; Boyes J
    Biochem J; 2014 Jul; 461(1):1-13. PubMed ID: 24927119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
    Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference: new mechanisms for targeted treatment?
    Woessmann W; Damm-Welk C; Fuchs U; Borkhardt A
    Rev Clin Exp Hematol; 2003 Sep; 7(3):270-91. PubMed ID: 15024970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vector-mediated RNAi and its use for cancer research.
    Sumimoto H; Kawakami Y
    Future Oncol; 2007 Dec; 3(6):655-64. PubMed ID: 18041918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in research on RNA interference-related drugs for cancer treatment].
    Ren HW; Yang BX
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):801-4. PubMed ID: 23291125
    [No Abstract]   [Full Text] [Related]  

  • 16. [Small interfering RNA mediated multi-target therapy of cancer].
    Shao RG
    Yao Xue Xue Bao; 2009 Mar; 44(3):219-25. PubMed ID: 19449517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of RNA interference in mammalian systems.
    Martin SE; Caplen NJ
    Annu Rev Genomics Hum Genet; 2007; 8():81-108. PubMed ID: 17477824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of RNAi to cancer therapy].
    Tan YL; Yin JQ
    Yao Xue Xue Bao; 2005 Mar; 40(3):193-8. PubMed ID: 15952587
    [No Abstract]   [Full Text] [Related]  

  • 19. Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?
    Guo J; Evans JC; O'Driscoll CM
    Trends Mol Med; 2013 Apr; 19(4):250-61. PubMed ID: 23499575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dicey role of Dicer: implications for RNAi therapy.
    Merritt WM; Bar-Eli M; Sood AK
    Cancer Res; 2010 Apr; 70(7):2571-4. PubMed ID: 20179193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.